These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 14629744)
1. Phenylephrine induces endogenous noradrenaline release in the rat vas deferens through nitric oxide synthase pathway. Pinto R; Barrento C; Mota-Filipe H; Lima BS Pharmacol Toxicol; 2003 Oct; 93(4):191-6. PubMed ID: 14629744 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase/guanylate cyclase pathway modulates the rat vas deferens contractility induced by phenylephrine. Pinto R; Mota-Filipe H; Lima BS Pharmacol Toxicol; 2002 Oct; 91(4):179-84. PubMed ID: 12530468 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. Burt RP; Chapple CR; Marshall I Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Aboud R; Shafii M; Docherty JR Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642 [TBL] [Abstract][Full Text] [Related]
5. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta. Adeagbo AS; Triggle CR Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta. Joly GA; Narayanan K; Griffith OW; Kilbourn RG Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462 [TBL] [Abstract][Full Text] [Related]
7. Influence of castration on the response of the rat vas deferens to fluoxetine. Busch L; Wald M; Borda E Pharmacol Res; 2000 Oct; 42(4):305-11. PubMed ID: 10987988 [TBL] [Abstract][Full Text] [Related]
8. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat. Priest RM; Hucks D; Ward JP Br J Pharmacol; 1997 Dec; 122(7):1375-84. PubMed ID: 9421285 [TBL] [Abstract][Full Text] [Related]
9. Effects of desipramine on prazosin potency at α1A- and α1D-adrenoceptors in rat vas deferens: implications for the α1L-adrenoceptor subclassification. Docherty JR Eur J Pharmacol; 2014 Dec; 744():183-9. PubMed ID: 25446564 [TBL] [Abstract][Full Text] [Related]
10. Two new nitric oxide synthase inhibitors: pyridoxal aminoguanidine and 8-quinolinecarboxylic hydrazide selectively inhibit basal but not agonist-stimulated release of nitric oxide in rat aorta. Pekiner C; Kelicen P; Uma S; Miwa I Pharmacol Res; 2002 Oct; 46(4):317-20. PubMed ID: 12361692 [TBL] [Abstract][Full Text] [Related]
11. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake. Sallés J; Badia A Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783 [TBL] [Abstract][Full Text] [Related]
12. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen. Teng CM; Guh JH; Ko FN Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030 [TBL] [Abstract][Full Text] [Related]
13. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase. Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112 [TBL] [Abstract][Full Text] [Related]
14. Effect of the vascular endothelium on contractions induced by noradrenaline and phenylephrine in perforating branch of the human internal mammary artery. Pesić S; Grbović L; Jovanović A; Radenković M; Stojić D Pol J Pharmacol; 2003; 55(4):581-93. PubMed ID: 14581717 [TBL] [Abstract][Full Text] [Related]
15. Responsiveness to noradrenaline in aorta from wild-type, nitric oxide synthase-2, nitric oxide synthase-3 and alpha2A/D-adrenoceptor knockout mice. Vandeputte C; Aiden McCormick P; Docherty JR Eur J Pharmacol; 2003 Apr; 466(1-2):129-36. PubMed ID: 12679149 [TBL] [Abstract][Full Text] [Related]
16. The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine. Bruck H; Gössl M; Spitthöver R; Schäfers RF; Kohnle M; Philipp T; Wenzel RR J Hypertens; 2001 May; 19(5):907-11. PubMed ID: 11393674 [TBL] [Abstract][Full Text] [Related]
17. Involvement of alpha-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta. Kaneko K; Sunano S Eur J Pharmacol; 1993 Aug; 240(2-3):195-200. PubMed ID: 8243538 [TBL] [Abstract][Full Text] [Related]
18. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836 [TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine. Frew JD; Paisley K; Martin W Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774 [TBL] [Abstract][Full Text] [Related]
20. The influence of chronic inhibition of nitric oxide synthesis on contractile and relaxant properties of rat carotid and mesenteric arteries. Heijenbrok FJ; Mathy MJ; Pfaffendorf M; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):504-11. PubMed ID: 11138842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]